Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-effectiveness of a community-based dementia support model: evidence from a real-world economic evaluation.

Cost effectiveness and resource allocation : C/E·2026

Same author

Fibronectin matrix remodelling modulates the active nematic dynamics of cancer-associated fibroblasts.

Nature materials·2026

Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Ordering spontaneous flows and aging in active fluids depositing tracks.

Physical review. E·2025

Same author

Active Nematic Flows over Curved Surfaces.

Physical review letters·2022

Same author

Providers as Stakeholders in Addressing Implementation Barriers to Youth Mental Healthcare.

Community mental health journal·2021

Same journal

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026

Same journal

We Care, and We Will Listen.

Primary care·2026

Same journal

Addressing Sexual Health in Primary Care.

Primary care·2026

Same journal

Diagnosis and Management of Eating Disorders in Adolescents and Young Adults.

Primary care·2026

Same journal

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment.

Primary care·2026

Same journal

Nonpharmacologic Management of Insomnia Disorder in Primary Care.

Primary care·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 14, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Depression Updates and Selective Serotonin Reuptake Inhibitor Management.

Matteo Leveroni¹, Shane Jones¹, Samuel Bell²

¹UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA.

|May 12, 2026

Summary

This summary is machine-generated.

Routine screening and evidence-based treatments like selective serotonin reuptake inhibitors (SSRIs) are crucial for managing depression in primary care, especially for adolescents. Effective management improves symptom reduction and remission rates.

Keywords:

Antidepressant Depression SSRI Suicidality

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 14, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Area of Science:

Primary Care Medicine
Psychiatry
Adolescent Health

Background:

Depression is a growing public health concern, particularly in primary care settings and among adolescents.
Routine screening for depression is supported by evidence, showing benefits in remission and symptom reduction for adults and perinatal populations.

Purpose of the Study:

To review the evidence supporting depression screening in primary care.
To discuss effective first-line treatments for depression, including psychotherapy and pharmacotherapy.
To highlight the role of primary care clinicians in managing depression.

Main Methods:

Literature review of evidence supporting depression screening.
Analysis of first-line treatment efficacy for depression.
Discussion of selective serotonin reuptake inhibitors (SSRIs) as preferred pharmacotherapy.

Main Results:

Psychotherapy and pharmacotherapy demonstrate similar efficacy in reducing depressive symptoms.
Selective serotonin reuptake inhibitors (SSRIs) are effective outpatient antidepressants, superior to placebo.
SSRIs are generally safe across various patient groups, including pregnant, breastfeeding, and geriatric individuals, but require careful selection.

Conclusions:

Primary care plays a vital role in the individualized, evidence-based management of depression.
Routine screening and appropriate treatment selection are key to improving patient outcomes.
Clinicians must consider patient-specific factors when prescribing antidepressants like SSRIs.